NDC00074-6664-02: SODIUM LACTATE INJECTION.
The SODIUM LACTATE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, special_features: 20 ML. FLIPTOP VIAL, primary_container_type: VIAL, therapeutic_equivalent: NOT RATED, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 50.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-169-5319, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | 20 ML. FLIPTOP VIAL |
| primary_container_type | VIAL |
| therapeutic_equivalent | NOT RATED |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 50 |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 MILLIEQUIVALENTS SODIUM LACTATE PER MILLILITER |
| NSN | 6505-01-169-5319 |
| THERAPEUTIC EQUIVALENT | NOT RATED |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | 20 ML. FLIPTOP VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIEQUIVALENTS SODIUM LACTATE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 50 |
No substitute or cross-reference records for this part.